tiprankstipranks
Trending News
More News >
Max Healthcare Institute Ltd (IN:MAXHEALTH)
:MAXHEALTH
India Market

Max Healthcare Institute Ltd (MAXHEALTH) Stock Forecast & Price Target

Compare
6 Followers
See the Price Targets and Ratings of:

MAXHEALTH Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Max
Healthcare Institute Ltd
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MAXHEALTH Stock 12 Month Forecast

There Are No Analyst Ratings for IN:MAXHEALTH In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MAXHEALTH Financial Forecast

MAXHEALTH Earnings Forecast

Next quarter’s earnings estimate for MAXHEALTH is ₹4.70 with a range of ₹4.01 to ₹5.28. The previous quarter’s EPS was ₹5.02. MAXHEALTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.
Next quarter’s earnings estimate for MAXHEALTH is ₹4.70 with a range of ₹4.01 to ₹5.28. The previous quarter’s EPS was ₹5.02. MAXHEALTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.

MAXHEALTH Sales Forecast

Next quarter’s sales forecast for MAXHEALTH is ₹26.81B with a range of ₹26.28B to ₹27.34B. The previous quarter’s sales results were ₹21.35B. MAXHEALTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.
Next quarter’s sales forecast for MAXHEALTH is ₹26.81B with a range of ₹26.28B to ₹27.34B. The previous quarter’s sales results were ₹21.35B. MAXHEALTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on IN:MAXHEALTH
Goldman Sachs
Goldman Sachs
₹1,325
Buy
10.20%
Upside
Initiated
12/07/25
Geojit Research Analyst forecast on IN:MAXHEALTH
Unknown Analyst
Geojit Research
Not Ranked
Geojit Research
₹1,240₹1,280
Hold
6.46%
Upside
Downgraded
09/02/25
Geojit Research downgrades Max Healthcare Institute Ltd (MAXHEALTH) to a Hold
Kotak Mahindra Analyst forecast on IN:MAXHEALTH
Kotak Mahindra
Kotak Mahindra
₹1,070₹1,140
Sell
-5.19%
Downside
Reiterated
08/18/25
Kotak Mahindra Remains a Sell on Max Healthcare Institute Ltd (MAXHEALTH)
Jefferies Analyst forecast on IN:MAXHEALTH
Jefferies
Jefferies
₹1,400₹1,500
Buy
24.76%
Upside
Reiterated
08/14/25
Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,500.00 (from INR1,400.00) while maintaining a Buy rating.
Citi
₹1,250₹1,460
Buy
21.43%
Upside
Reiterated
08/11/25
Citi Remains a Buy on Max Healthcare Institute Ltd (MAXHEALTH)
HSBC
₹1,055₹1,145
Hold
-4.77%
Downside
Reiterated
07/17/25
HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)
J.P. Morgan Analyst forecast on IN:MAXHEALTH
J.P. Morgan
J.P. Morgan
₹1,390₹1,325
Buy
10.20%
Upside
Reiterated
05/22/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.
Bank of America Securities Analyst forecast on IN:MAXHEALTH
Bank of America Securities
Bank of America Securities
₹1,100₹1,170
Hold
-2.69%
Downside
Reiterated
05/21/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.
Macquarie
₹615
Sell
-48.85%
Downside
Reiterated
03/28/25
Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on IN:MAXHEALTH
Goldman Sachs
Goldman Sachs
₹1,325
Buy
10.20%
Upside
Initiated
12/07/25
Geojit Research Analyst forecast on IN:MAXHEALTH
Unknown Analyst
Geojit Research
Not Ranked
Geojit Research
₹1,240₹1,280
Hold
6.46%
Upside
Downgraded
09/02/25
Geojit Research downgrades Max Healthcare Institute Ltd (MAXHEALTH) to a Hold
Kotak Mahindra Analyst forecast on IN:MAXHEALTH
Kotak Mahindra
Kotak Mahindra
₹1,070₹1,140
Sell
-5.19%
Downside
Reiterated
08/18/25
Kotak Mahindra Remains a Sell on Max Healthcare Institute Ltd (MAXHEALTH)
Jefferies Analyst forecast on IN:MAXHEALTH
Jefferies
Jefferies
₹1,400₹1,500
Buy
24.76%
Upside
Reiterated
08/14/25
Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,500.00 (from INR1,400.00) while maintaining a Buy rating.
Citi
₹1,250₹1,460
Buy
21.43%
Upside
Reiterated
08/11/25
Citi Remains a Buy on Max Healthcare Institute Ltd (MAXHEALTH)
HSBC
₹1,055₹1,145
Hold
-4.77%
Downside
Reiterated
07/17/25
HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)
J.P. Morgan Analyst forecast on IN:MAXHEALTH
J.P. Morgan
J.P. Morgan
₹1,390₹1,325
Buy
10.20%
Upside
Reiterated
05/22/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.
Bank of America Securities Analyst forecast on IN:MAXHEALTH
Bank of America Securities
Bank of America Securities
₹1,100₹1,170
Hold
-2.69%
Downside
Reiterated
05/21/25
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.
Macquarie
₹615
Sell
-48.85%
Downside
Reiterated
03/28/25
Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Max Healthcare Institute Ltd

1 Month
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+8.93%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +8.93% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+5.30%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.30% per trade.
1 Year
Alankar GarudeKotak Mahindra
Success Rate
3/3 ratings generated profit
100%
Average Return
+10.93%
reiterated a sell rating 4 months ago
Copying Alankar Garude's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.93% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+10.93%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MAXHEALTH Analyst Recommendation Trends

Rating
May 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
1
2
4
3
2
Hold
2
3
6
7
7
Sell
2
1
1
1
1
Strong Sell
0
0
0
0
0
total
5
6
11
11
10
In the current month, MAXHEALTH has received 2 Buy Ratings, 7 Hold Ratings, and 1 Sell Ratings. MAXHEALTH average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MAXHEALTH Stock Forecast FAQ

What is IN:MAXHEALTH’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:MAXHEALTH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:MAXHEALTH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Max Healthcare Institute Ltd a Buy, Sell or Hold?
      Currently, no data Available
      What is Max Healthcare Institute Ltd’s share price target?
      Currently, no data Available
      What do analysts say about Max Healthcare Institute Ltd?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Max Healthcare Institute Ltd?
      To buy shares of IN:MAXHEALTH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.